Analyst Ratings for BeOne Medicines (ONC)
ONC Rating Summary
ONC Price Target Summary
- Highest: $430.00 (Citi)
- Lowest: $250.00 (Aletheia Capital)
- Average: $392.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$392.00 (+30.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$392.00 (+30.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/24/2025 | Truist Securities » Updated 2/27/2026 |
N/A | New Coverage | Buy (N/A) |
412.00 (400.00) |
347.72 (301.12) |
-13.4% | Details |
| 9/18/2025 | Barclays » Updated 2/27/2026 |
Peter Lawson | New Coverage | Overweight (N/A) |
405.00 (394.00) |
327.20 (301.12) |
-7.97% | Details |
 |
||||||||
|
||||||||
